Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 12:57 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 217–240 of 7,882 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Non intervention study Clear all

Conditions: Congenital Thrombotic Thrombocytopenic Purpura
Interventions: No intervention; Other
Lead sponsor: Baxalta now part of Shire; Industry
Eligibility: 12 Years and older
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Atlanta, Georgia • Houston, Texas

Conditions: Obstructive Sleep Apnea, OSA, Sleep Apnea
Interventions: Dimethyl fumarate, Placebo; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 65 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Urologic Diseases
Interventions: Stream Dx, DFree, TestCard; Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Non-Alcoholic Fatty Liver Disease
Interventions: Sigmoidoscopy; Procedure
Lead sponsor: AdventHealth Translational Research Institute; Other
Eligibility: 35 Years to 65 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Obesity, Childhood
Interventions: Improving Pediatric Obesity Practice Using Prompts (iPOP-UP); Behavioral
Lead sponsor: Yale University; Other
Eligibility: 2 Years and older
Enrollment: 58,364 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 3
States / cities: Indianapolis, Indiana • Durham, North Carolina • Philadelphia, Pennsylvania

Conditions: Pain
Interventions: Acupuncture; Other
Lead sponsor: Allina Health System; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Polyneuropathies, Wild Type ATTR Amyloidosis, Wild-Type Transthyretin-Related (ATTR)Amyloidosis, Wild-Type Transthyretin Cardiac Amyloidosis, Transthyretin Amyloidosis
Interventions: patisiran; Drug
Lead sponsor: Austin Neuromuscular Center; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Dental Malocclusion, Angle Class II, Angle Class I, Crowding, Tooth
Interventions: BRIUS; Device
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 10 Years to 17 Years
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Restless Legs Syndrome
Interventions: MMF07 Foot Massager, Heat Therapy; Device
Lead sponsor: Ariane Park; Other
Eligibility: 18 Years to 75 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma
Interventions: Atezolizumab Injection, Bevacizumab, Transarterial chemoembolization; Drug · Combination Product
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Weight Gain, Obesity
Interventions: GEM, Enhanced Usual Care; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 69 Years
Enrollment: 489 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Head and Neck Cancer, Body Image Disturbance, Body Image, Survivorship, Psychosocial Impairment, Mental Health Issue
Interventions: BRIGHT, Attention Control; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 5
States / cities: Detroit, Michigan • St Louis, Missouri • Hershey, Pennsylvania + 2 more

Conditions: Diabetic Foot Ulcers
Interventions: V.A.C. Negative Pressure Wound Therapy System; Device
Lead sponsor: KCI USA, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 6
States / cities: New Haven, Connecticut • South Miami, Florida • Bethlehem, Pennsylvania + 2 more

Conditions: Migraine Disorders, Refractory Migraine, Chronic Migraine
Interventions: TEMMA Endovascular Treatment; Device
Lead sponsor: Cortex Neurovascular; Industry
Eligibility: 18 Years to 60 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2028 – 2032
U.S. locations: 1
States / cities: Tacoma, Washington

Conditions: Healthy
Interventions: Virtual Promotoras Program; Behavioral
Lead sponsor: University of Alabama, Tuscaloosa; Other
Eligibility: 16 Years to 21 Years · Female only
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Tuscaloosa, Alabama

Conditions: Pulmonary Embolism, Pulmonary Embolism Subacute Massive
Interventions: inhaled nitric oxide (iNO); Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Alcohol Use, Unspecified
Interventions: Episodic Future thinking, Volitional choice, Monitoring only; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Relapsing Multiple Sclerosis
Interventions: Blood sampling; Other
Lead sponsor: EMD Serono; Industry
Eligibility: 18 Years and older
Enrollment: 324 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Rockland, Massachusetts

Conditions: Acute Myeloid Leukemia
Interventions: Crenolanib, Sorafenib, methotrexate, hydrocortisone and cytarabine with leucovorin; Drug
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 1 Year to 39 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Reproductive Health
Interventions: OKQ Training Program; Behavioral
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 49 Years · Female only
Enrollment: 143 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Cancer, Melanoma
Interventions: Radiation Therapy, Cisplatin, Surgical resection; Radiation · Drug · Procedure
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 2
States / cities: Salt Lake City, Utah

Conditions: Quadriplegia
Interventions: Neural Prosthetic System 2 (NPS2); Device
Lead sponsor: Richard A. Andersen, PhD; Other
Eligibility: 22 Years to 65 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2029
U.S. locations: 4
States / cities: Downey, California • Los Angeles, California • Pasadena, California + 1 more

Conditions: Cancer
Interventions: mychoiceTM; Behavioral
Lead sponsor: Fox Chase Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Type 1 Diabetes Mellitus, Exercise Physiology
Interventions: Standard-of-Care Guidance (SoC), Usual Care (UC), netIOB & Exercise Toolkit (NEXT), Continuous Glucose Monitoring, Continuous Ketone Monitoring; Behavioral · Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Palo Alto, California

Search by objective public record fields.

Prospective Psychometric Evaluation Study of a Patient-reported Outcomes (PRO) Instrument for Congenital Thrombotic Thrombocytopenic Purpura (cTTP, Upshaw-Schulman Syndrome [USS], Hereditary Thrombotic Thrombocytopenic Purpura [hTTP]

Dimethyl Fumarate for Obstructive Sleep Apnea

Patient Satisfaction of Virtual vs In-Person Workup and Treatment of Lower Urinary Tract Symptoms.

Microbiome-Mediated Gut Dysfunction in Non-Alcoholic Fatty Liver Disease

Dissemination and Implementation of Improving Pediatric Obesity Practice Using Prompts

Acupuncture in the Emergency Department

Spectrum of Peripheral and Autonomic Neuropathies in Patients With aTTRwt Amyloidosis and Response to Patisiran Therapy

BRIUS Vs FFA Efficiency

A Study on the Use of the MMF07 Foot Massager and Heat Therapy Treatments for Restless Leg Syndrome

Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC

The GEM (Goals for Eating and Moving) Study

Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT

Evaluating the Ease of Use of a VAC GranuFoam Bridge Dressing on Diabetic Foot Ulcers Receiving VAC Negative Pressure Wound Therapy

EMBRACE Study: Enduring Migraine Benefit From Responsive Artery Coil Embolization

The Virtual Promotoras Study: eHealth Intervention to Promote Sexual Health Among Young Latina Women in the US South

Effect of iNO in Patients With Submassive and Massive PE

Behavioral Economic Treatment to Enhance Rural (BETTER) Living

The REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial

Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies

One Key Question: Pilot Study at NorthShore

Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma

Sensory Motor Transformations in Human Cortex

mychoiceTM Implementation With Medical Oncology Patients

Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise